These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 23484193)

  • 1. Antifibrotic effect of combined treatment with neuroleptic drug and immobilized hyaluronidase in pulmonary fibrosis.
    Dygai AM; Skurikhin EG; Ermakova NN; Pershina OV; Krupin VA; Reztsova AM; Ermolaeva LA; Khmelevskaya ES; Stepanova IE; Artamonov AV; Bekarev AA; Madonov PG; Kinsht DN; Goldberg VE; Semiglazova TA
    Bull Exp Biol Med; 2013 Jan; 154(3):329-33. PubMed ID: 23484193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifibrotic activity of hyaluronidase immobilized on polyethylenoxide under conditions of bleomycin-induced pneumofibrosis.
    Dygai AM; Skurikhin EG; Ermakova NN; Pershina OV; Krupin VA; Reztsova AM; Ermolaeva LA; Khmelevskaya ES; Artamonov AV; Bekarev AA; Madonov PG; Kinsht DN
    Bull Exp Biol Med; 2013 Jan; 154(3):388-92. PubMed ID: 23484207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory and antifibrotic effects of a combination of spiperone and immobilized hyaluronidase on partially reversible and irreversible toxic pneumofibrosis.
    Skurikhin EG; Ermakova NN; Reztsova AM; Pershina OV; Khmelevskaya ES; Krupin VA; Stepanova IE; Reztsova VM; Reihard DV; Artamonov AV; Bekarev AA; Madonov PG; Kinsht DN; Goldberg VE; Dygai AM
    Bull Exp Biol Med; 2013 Nov; 156(1):53-8. PubMed ID: 24319728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifibrotic effects of immobilized hyaluronidase in repeated bleomycin-induced lesions of the alveolar epithelium.
    Dygai AM; Skurikhin EG; Ermakova NN; Reztsova AM; Pershina OV; Khmelevskaya ES; Krupin VA; Stepanova IE; Reztsova VM; Artamonov AV; Bekarev AA; Madonov PG; Kinsht DN
    Bull Exp Biol Med; 2013 Aug; 155(4):501-6. PubMed ID: 24143378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifibrotic and anti-inflammatory activity of a neuroleptic drug on the model of pulmonary fibrosis.
    Dygai AM; Skurikhin EG; Andreeva TV; Pershina OV; Ermolaeva LA; Khmelevskaya ES; Krupin VA; Reztsova AM; Stepanova IE
    Bull Exp Biol Med; 2012 Apr; 152(6):679-83. PubMed ID: 22803163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of bleomycin-induced lung fibrosis by pegylated hyaluronidase and dopamine receptor antagonist in mice.
    Skurikhin EG; Pershina OV; Reztsova AM; Ermakova NN; Khmelevskaya ES; Krupin VA; Stepanova IE; Artamonov AV; Bekarev AA; Madonov PG; Dygai AM
    PLoS One; 2015; 10(4):e0125065. PubMed ID: 25927611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of immobilized hyaluronidase on stem and progenitor cells in pulmonary fibrosis.
    Dygai AM; Skurikhin EG; Khmelevskaya ES; Ermakova NN; Reztsova AM; Pershina OV; Krupin VA; Stepanova IE; Reztsova VM; Artamonov AV; Bekarev AA; Madonov PG; Kinsht DN
    Bull Exp Biol Med; 2014 Feb; 156(4):590-4. PubMed ID: 24771454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of the anti-inflammatory and antifibrotic activity of a sympatholytic agent during toxic pulmonary fibrosis.
    Skurikhin EG; Khmelevskaya ES; Pershina OV; Andreeva TV; Ermolaeva LA; Krupin VA; Ermakova NN; Reztsova AM; Stepanova IE; Dygai AM
    Bull Exp Biol Med; 2012 Sep; 153(5):638-43. PubMed ID: 23113245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-fibrotic effects of chronic treatment with the selective FXR agonist obeticholic acid in the bleomycin-induced rat model of pulmonary fibrosis.
    Comeglio P; Filippi S; Sarchielli E; Morelli A; Cellai I; Corcetto F; Corno C; Maneschi E; Pini A; Adorini L; Vannelli GB; Maggi M; Vignozzi L
    J Steroid Biochem Mol Biol; 2017 Apr; 168():26-37. PubMed ID: 28115235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micellar Hyaluronidase and Spiperone as a Potential Treatment for Pulmonary Fibrosis.
    Skurikhin E; Madonov P; Pershina O; Ermakova N; Pakhomova A; Widera D; Pan E; Zhukova M; Sandrikina L; Artamonov A; Dygai A
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase inhibitor restores surfactant protein-C expression in alveolar-epithelial type II cells and attenuates bleomycin-induced pulmonary fibrosis in vivo.
    Ota C; Yamada M; Fujino N; Motohashi H; Tando Y; Takei Y; Suzuki T; Takahashi T; Kamata S; Makiguchi T; Yamaya M; Kubo H
    Exp Lung Res; 2015; 41(8):422-34. PubMed ID: 26151196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance of fibrogenic responses to glucocorticoid and 2-methoxyestradiol in bleomycin-induced lung fibrosis in mice.
    Langenbach SY; Wheaton BJ; Fernandes DJ; Jones C; Sutherland TE; Wraith BC; Harris T; Schuliga MJ; McLean C; Stewart AG
    Can J Physiol Pharmacol; 2007 Jul; 85(7):727-38. PubMed ID: 17823636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifibrotic activity of conjugates based on amphiphilic pluronic F68 and hydrophobic pluronic L31 with hyaluronate-endo-β-N-acetylhexosaminidase in pulmonary fibrosis.
    Skurikhin EG; Reztsova AM; Ermakova NN; Krupin VA; Pershina OV; Khmelevskaya ES; Artamonov AV; Bekarev AA; Madonov PG; Kinsht DN; Reykhard DV; Goldberg VE; Dygai AM
    Bull Exp Biol Med; 2014 May; 157(1):5-9. PubMed ID: 24906958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of spiperone on mesenchymal multipotent stromal and hemopoietic stem cells under conditions of pulmonary fibrosis.
    Skurikhin EG; Khmelevskaya ES; Ermakova NN; Pershina OV; Reztsova AM; Krupin VA; Stepanova IE; Reztsova VM; Reikhart DV; Dygai AM
    Bull Exp Biol Med; 2014 May; 157(1):132-7. PubMed ID: 24913578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration in Intrapulmonary Pharmacokinetics of Aerosolized Model Compounds Due to Disruption of the Alveolar Epithelial Barriers Following Bleomycin-Induced Pulmonary Fibrosis in Rats.
    Togami K; Chono S; Tada H
    J Pharm Sci; 2016 Mar; 105(3):1327-34. PubMed ID: 26886341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-HT7 receptor antagonism (SB-269970) attenuates bleomycin-induced pulmonary fibrosis in rats via downregulating oxidative burden and inflammatory cascades and ameliorating collagen deposition: Comparison to terguride.
    Tawfik MK; Makary S
    Eur J Pharmacol; 2017 Nov; 814():114-123. PubMed ID: 28821451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uridine supplementation exerts anti-inflammatory and anti-fibrotic effects in an animal model of pulmonary fibrosis.
    Cicko S; Grimm M; Ayata K; Beckert J; Meyer A; Hossfeld M; Zissel G; Idzko M; Müller T
    Respir Res; 2015 Sep; 16(1):105. PubMed ID: 26369416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
    Adamson IY; Bowden DH
    Am J Pathol; 1974 Nov; 77(2):185-97. PubMed ID: 4141224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratracheal transplantation of alveolar type II cells reverses bleomycin-induced lung fibrosis.
    Serrano-Mollar A; Nacher M; Gay-Jordi G; Closa D; Xaubet A; Bulbena O
    Am J Respir Crit Care Med; 2007 Dec; 176(12):1261-8. PubMed ID: 17641155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A neutrophil elastase inhibitor prevents bleomycin-induced pulmonary fibrosis in mice.
    Takemasa A; Ishii Y; Fukuda T
    Eur Respir J; 2012 Dec; 40(6):1475-82. PubMed ID: 22441751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.